Family practice · 2009
GP-led melanoma follow-up: the practical experience of GPs.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Murchie Peter, Delaney Elizabeth K, Campbell Neil C, Hannaford Philip C
Аннотация
OBJECTIVES: To explore how GP-led melanoma follow-up had actually worked from the perspective of GPs by exploring in detail the practical experience of GPs running the programme.
DESIGN: Semi-structured audio-taped telephone interviews with GPs delivering a GP-led follow-up programme for people with cutaneous malignant melanoma.
SUBJECTS: Seventeen GPs currently delivering structured GP-led routine follow-up for people with cutaneous melanoma.
RESULTS: GP-led melanoma follow-up worked well from the perspectives of GPs. The GPs felt that they were well equipped and supported in undertaking the follow-up consultations and recognized that they were freeing up hospital consultant time. They felt that patients appreciated the convenience of GP-led follow-up. The GPs felt that a robust recall system, initial training with regular refreshers and effective consultant backup were vital components of a successful long-term programme.
CONCLUSIONS: GP-led melanoma follow-up is feasible and, provided certain concerns can be addressed, GPs are willing to provide it.
DESIGN: Semi-structured audio-taped telephone interviews with GPs delivering a GP-led follow-up programme for people with cutaneous malignant melanoma.
SUBJECTS: Seventeen GPs currently delivering structured GP-led routine follow-up for people with cutaneous melanoma.
RESULTS: GP-led melanoma follow-up worked well from the perspectives of GPs. The GPs felt that they were well equipped and supported in undertaking the follow-up consultations and recognized that they were freeing up hospital consultant time. They felt that patients appreciated the convenience of GP-led follow-up. The GPs felt that a robust recall system, initial training with regular refreshers and effective consultant backup were vital components of a successful long-term programme.
CONCLUSIONS: GP-led melanoma follow-up is feasible and, provided certain concerns can be addressed, GPs are willing to provide it.